These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11296960

  • 1. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD, Cheah SP, Taylor K, Ahern MJ.
    J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
    [Abstract] [Full Text] [Related]

  • 2. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
    Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah I, Chow SK, Goh EM.
    J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
    [Abstract] [Full Text] [Related]

  • 3. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.
    Adachi J, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, Craig GL, Kaminska E, Sebaldt RJ, Papaioannou A.
    J Rheumatol; 1994 Oct; 21(10):1922-6. PubMed ID: 7837160
    [Abstract] [Full Text] [Related]

  • 4. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
    Buckley LM, Marquez M, Feezor R, Ruffin DM, Benson LL.
    Arthritis Rheum; 1999 Aug; 42(8):1736-9. PubMed ID: 10446875
    [Abstract] [Full Text] [Related]

  • 5. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T, Maekawa S, Morinobu S, Morinobu A, Koshiba M, Yamauchi M, Sugimoto T, Kumagai S.
    Ryumachi; 2002 Aug; 42(4):666-75. PubMed ID: 12355861
    [Abstract] [Full Text] [Related]

  • 6. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
    Sato S, Takada T, Katsuki Y, Kimura N, Kaneko Y, Suwa A, Hirakata M, Kuwana M.
    J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
    [Abstract] [Full Text] [Related]

  • 7. High-dose corticosteroid exposure and osteoporosis intervention in adults.
    Che M, Ettinger B, Nguyen MT, Pressman AR, Johnston J.
    Ann Allergy Asthma Immunol; 2006 Oct; 97(4):497-501. PubMed ID: 17069105
    [Abstract] [Full Text] [Related]

  • 8. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
    Lambrinoudaki I, Chan DT, Lau CS, Wong RW, Yeung SS, Kung AW.
    J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
    [Abstract] [Full Text] [Related]

  • 9. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.
    Smith MD, Ross W, Ahern MJ.
    J Rheumatol; 2001 Nov; 28(11):2504-8. PubMed ID: 11708425
    [Abstract] [Full Text] [Related]

  • 10. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 11. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.
    J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
    [Abstract] [Full Text] [Related]

  • 12. Low bone mineral density in adult patients with moderate to severe atopic dermatitis.
    Haeck IM, Hamdy NA, Timmer-de Mik L, Lentjes EG, Verhaar HJ, Knol MJ, de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    Br J Dermatol; 2009 Dec; 161(6):1248-54. PubMed ID: 19673879
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM, Valeriano J, Vasey FB, Carter JD.
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [Abstract] [Full Text] [Related]

  • 14. Is enough attention being given to the adverse effects of corticosteroid therapy?
    Hougardy DM, Peterson GM, Bleasel MD, Randall CT.
    J Clin Pharm Ther; 2000 Jun; 25(3):227-34. PubMed ID: 10886467
    [Abstract] [Full Text] [Related]

  • 15. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
    Buckley LM, Marquez M, Hudson JO, Downs RW, Vacek P, Small RE, Poses R.
    J Rheumatol; 1998 Nov; 25(11):2195-202. PubMed ID: 9818664
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
    Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ, Tugwell P, Gordon M, Steele M, Webber C, Goldsmith CH.
    J Rheumatol; 1996 Jun; 23(6):995-1000. PubMed ID: 8782129
    [Abstract] [Full Text] [Related]

  • 17. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.
    Walsh LJ, Wong CA, Pringle M, Tattersfield AE.
    BMJ; 1996 Aug 10; 313(7053):344-6. PubMed ID: 8760745
    [Abstract] [Full Text] [Related]

  • 18. Alendronate for the prevention of bone mineral loss during gonadotropin-releasing hormone agonist therapy.
    Ripps BA, VanGilder K, Minhas B, Welford M, Mamish Z.
    J Reprod Med; 2003 Oct 10; 48(10):761-6. PubMed ID: 14619641
    [Abstract] [Full Text] [Related]

  • 19. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].
    Ieda Y, Nagasaka Y.
    Clin Calcium; 2007 Jun 10; 17(6):955-62. PubMed ID: 17548937
    [Abstract] [Full Text] [Related]

  • 20. Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment.
    Solomon DH, Levin E, Helfgott SM.
    J Rheumatol; 2000 Jun 10; 27(6):1496-500. PubMed ID: 10852277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.